Valerion Therapeutics, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Valerion Therapeutics, LLC.The latest application filed is for "methods and compositions for treatment of protein aggregation-based disorders".

Company Profile

14.24.19

Valerion Therapeutics, LLC - Concord MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Treatment Of Protein Aggregation-based Disorders App 20210395716 - Armstrong; Dustin D.	2021-12-23
Methods And Compositions For Treatment Of Polyglucosan Disorders App 20210040464 - Armstrong; Dustin D. ; et al.	2021-02-11
Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders Grant 10,781,434 - Armstrong Sept	2020-09-22
Methods and compositions for treatment of Lafora disease Grant 10,781,433 - Armstrong Sept	2020-09-22
Methods And Compositions For Treatment Of Glycogen Storage Diseases And Glycogen Metabolism Disorders App 20200224184 - Armstrong; Dustin D.	2020-07-16
Internalizing moieties Grant 10,703,824 - Armstrong , et al.	2020-07-07
Internalizing moieties for treatment of cancer Grant 10,501,554 - Armstrong Dec	2019-12-10
Methods And Compositions For Treatment Of Lafora Disease App 20190316104 - Armstrong; Dustin D.	2019-10-17
Internalizing Moieties App 20190292276 - Armstrong; Dustin D. ; et al.	2019-09-26
Antisense conjugates for decreasing expression of DMPK Grant 10,238,753 - Armstrong	2019-03-26
Internalizing moieties Grant 10,221,250 - Armstrong , et al.	2019-03-05
Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders Grant 10,202,591 - Armstrong Feb	2019-02-12
Methods And Compositions For Treatment Of Pompe Disease App 20180251571 - Armstrong; Dustin D. ; et al.	2018-09-06
Methods and compositions for treatment of Pompe disease Grant 10,017,581 - Armstrong , et al. July 10, 2	2018-07-10
Internalizing Moieties For Treatment Of Cancer App 20180127509 - Armstrong; Dustin D.	2018-05-10
Methods And Compositions For Treatment Of Forbes-cori Disease App 20180028676 - Armstrong; Dustin D.	2018-02-01
Antisense Conjugates For Decreasing Expression Of Dmpk App 20180021449 - Armstrong; Dustin D.	2018-01-25
Internalizing Moieties App 20170174790 - ARMSTRONG; Dustin D. ; et al.	2017-06-22
Methods And Compositions For Treatment Of Glycogen Storage Diseases And Glycogen Metabolism Disorders App 20170130216 - Armstrong; Dustin D.	2017-05-11
Antisense conjugates for decreasing expression of DMPK Grant 9,610,362 - Armstrong April 4, 2	2017-04-04
Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides Grant 9,447,394 - Armstrong September 20, 2	2016-09-20
Methods And Compositions For Treatment Of Pompe Disease App 20160108133 - Armstrong; Dustin D. ; et al.	2016-04-21
Methods And Compositions For Treatment Of Forbes-cori Disease App 20160089451 - Armstrong; Dustin D.	2016-03-31
Methods and compositions for treatment of myotonic dystrophy Grant 9,114,178 - Armstrong August 25, 2	2015-08-25
Methods And Compositions For Treatment Of Myotubular Myopathy Using Chimeric Polypeptides Comprising Myotubularin 1(mtm1) Polypeptides App 20150218540 - Armstrong; Dustin D.	2015-08-06
Methods For Increasing Muscle Contractility App 20150152170 - Armstrong; Dustin D. ; et al.	2015-06-04
Antisense Conjugates For Decreasing Expression Of Dmpk App 20150064181 - Armstrong; Dustin D.	2015-03-05
Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides Grant 8,834,866 - Armstrong September 16, 2	2014-09-16
Methods And Compositions For Treatment Of Myotonic Dystrophy App 20140178377 - Armstrong; Dustin D.	2014-06-26
Methods and compositions for treatment of myotonic dystrophy Grant 8,609,615 - Armstrong December 17, 2	2013-12-17

Company Registrations

NCAGE Code	70AM9	VALERION THERAPEUTICS, LLC
CAGE Code	70AM9	VALERION THERAPEUTICS, LLC
S.A.M. Registration	70AM9 [79177173]	VALERION THERAPEUTICS, LLC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.